Last reviewed · How we verify
NCT07105761: BMS
Body-Mind-Spirit Action Group on the Well-being
NA trial testing Body-Mind-Spirit in Quality of Life (QOL) in 36 participants. Completed in 1 July 2024.
25 July 2023
Quick facts
| Lead sponsor | Taipei City Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 36 |
| Start date | 26 April 2023 |
| Primary completion | 25 July 2023 |
| Estimated completion | 1 July 2024 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Body-Mind-Spirit
Conditions studied
- Quality of Life (QOL) — all drugs for Quality of Life (QOL) →
- Depression — all drugs for Depression →
Sponsor
Taipei City Hospital
Who can join
Adults 20 to 95, any sex, with Quality of Life (QOL) or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Primary Purpose: To evaluate the effectiveness of a culturally adapted BMS group intervention on holistic well-being, depressive symptoms, sleep parameters, and quality of life in individuals with visual impairment. Study Objective: This study aims to find out whether a 10-week BMS group program can help people with visual impairment feel emotionally better, improve their overall well-being, enhance sleep quality, and experience a higher quality of life. Intervention Description: The BMS group meets once a week for 10 weeks, with each session lasting about 2 hours. Sessions include guided discussions, storytelling, and experiential activities drawn from both Eastern and Western philosophies. These practices focus on: Appreciating kindness in others Letting go of past hurt (forgiveness) Practicing mindfulness and living in the present moment What the Researchers Want to Know: Does the program help participants feel less depressed? Does it help them feel more balanced, hopeful, and connected in daily life? Does it improve their sleep and overall well-being? Participants: About 30 community-dwelling adults with visual impairment will take part in the study. They will be randomly assigned to one of two groups: The intervention group will join the BMS sessions for 10 weeks. The control group will continue their usual community activities with no new program. All participants will complete surveys at three points: before the program starts, at the midpoint (week 5), and after the program ends (week 10). These surveys assess levels of depression, well-being, sleep quality, and life satisfaction. Some participants in the BMS group will also be invited to join short interviews to share their experiences-such as feeling more grateful, confident, or resilient. Overall Goal: The goal of this study is to determine whether a supportive, culturally adapted group program can help people with vision loss feel stronger, less depressed, more connected, and better equipped to manage their daily lives. Previous findings suggest that BMS group therapy effectively enhances sleep duration and significantly improves quality of life-especially in psychological well-being-among visually impaired individuals. These findings support the integration of BMS therapy into holistic care strategies to promote emotional resilience, well-being, and personal growth in this population.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A pilot study of body-mind-spirit group therapy on sleep and quality of life in individuals with visual impairment.
Liu CR, Tseng MY, Sharma D, Hsieh WD, et al · · 2026 · PMID 42070200 · DOI 10.1007/s11136-026-04260-6
Verify or expand the search:
- PubMed search for NCT07105761
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Quality of Life (QOL)
Currently open trials in the same condition.
- NCT07210164 — Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study · NA · recruiting
- NCT06939426 — Music Therapy and Humanization in ED Healthcare Professionals · NA · recruiting
- NCT07027930 — A Feasibility Trial of Eye Movement Desensitization and Reprocessing Therapy- Integrative Treatment Group Protocol for O · NA · recruiting
- NCT07010939 — A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients · recruiting
- NCT06886451 — Vomiting Prevention in Children With Cancer · NA · recruiting
Other Taipei City Hospital trials
Trials by the same sponsor.
- NCT06337214 — TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy · NA · recruiting
- NCT07501546 — Enhancing Childhood Obesity Interventions Through Digital Media Tools · NA · completed
- NCT06139276 — Outcomes of Frozen Shoulder Treated With Small Needle-Knife Through Microcirculation and Pulse Analysis. · NA · unknown
- NCT06100198 — The Effect of Nutrition and Exercise Program on the Health of Community-dwelling Older Adults · NA · unknown
- NCT06601920 — A Study of Activity Leader to Forest Therapy Campaign in Different Environments Targets on the Participants Which Had Be · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07105761 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei City Hospital
- Last refreshed: 13 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07105761.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing